NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/15/2023
Back to search
Official data from USPTO
AAPS PHARMSCI360
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AAPS PHARMSCI360
ST13
US500000086926053Class
41
Filing
86926053
Registration
5317846
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/15/2023
Trademark type
Word
Nice classes
41
Filing date
03/02/2016
Registration date
10/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2023
Last transaction
12/15/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2017
First use in commerce
05/01/2017
Drawing code
4
Owner type
03
Owner location
Arlington, VA, US
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
American Association of Pharmaceutical Scientists
Representatives
William H Howe HOWE ANDERSON & SMITH PC
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Arranging and conducting educational conferences in the field of pharmaceutical science
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/15/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/19/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/16/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/16/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/14/2017
IUAF
USE AMENDMENT FILED
08/29/2017
EISU
TEAS STATEMENT OF USE RECEIVED
08/29/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2017
EX1G
SOU EXTENSION 1 GRANTED
01/09/2017
EXT1
SOU EXTENSION 1 FILED
01/09/2017
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/27/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2016
PUBO
PUBLISHED FOR OPPOSITION
08/02/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/29/2016
ALIE
ASSIGNED TO LIE
06/22/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/15/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/15/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/15/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/15/2016
DOCK
ASSIGNED TO EXAMINER
06/15/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
03/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/07/2016
NWAP
NEW APPLICATION ENTERED
03/05/2016
Continuous trademark protection
Get notified about every new filing that threatens AAPS PHARMSCI360 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.